Article Versions Notes

Liu X, Hu J, Song X, Utpatel K, Zhang Y, Wang P, Lu X, Zhang J, Xu M, Su T, et al. Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma. Cancers. 2019; 11(7):930. https://doi.org/10.3390/cancers11070930

Liu, Xianqiong, Junjie Hu, Xinhua Song, Kirsten Utpatel, Yi Zhang, Pan Wang, Xinjun Lu, Jie Zhang, Meng Xu, Tao Su, and et al. 2019. "Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma" Cancers 11, no. 7: 930. https://doi.org/10.3390/cancers11070930

Liu, X., Hu, J., Song, X., Utpatel, K., Zhang, Y., Wang, P., Lu, X., Zhang, J., Xu, M., Su, T., Che, L., Wang, J., Evert, M., Calvisi, D. F., & Chen, X. (2019). Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma. Cancers, 11(7), 930. https://doi.org/10.3390/cancers11070930